These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hepatotoxicity following the therapeutic use of antipyretic analgesics. Benson GD Am J Med; 1983 Nov; 75(5A):85-93. PubMed ID: 6359871 [TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity of non-narcotic analgesics. Tolman KG Am J Med; 1998 Jul; 105(1B):13S-19S. PubMed ID: 9715830 [TBL] [Abstract][Full Text] [Related]
7. Drug interactions affecting analgesic toxicity. Prescott LF; Critchley JA Am J Med; 1983 Nov; 75(5A):113-6. PubMed ID: 6359860 [TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. Auriel E; Regev K; Korczyn AD Handb Clin Neurol; 2014; 119():577-84. PubMed ID: 24365321 [TBL] [Abstract][Full Text] [Related]
9. Important role of prodromal viral infections responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye's syndrome, Stevens-Johnson syndrome, autoimmune hepatitis, and hepatotoxicity of the therapeutic doses of acetaminophen used in genetically predisposed persons. Prandota J Am J Ther; 2002; 9(2):149-56. PubMed ID: 11897929 [TBL] [Abstract][Full Text] [Related]
10. [Hepatotoxicity caused by therapeutic doses of paracetamol in alcoholics. Report of 2 cases of fatal hepatitis in cirrhosis]. Mofredj A; Cadranel JF; Darchy B; Barbare JC; Cazier A; Pras V; Biour M Ann Med Interne (Paris); 1999 Oct; 150(6):507-11. PubMed ID: 10615538 [TBL] [Abstract][Full Text] [Related]
11. A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience. Goldkind L; Laine L Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):213-20. PubMed ID: 16456879 [TBL] [Abstract][Full Text] [Related]
12. [Hepatitis due to nonsteroidal anti-inflammatory agents]. Furet Y; Metman EH; Breteau M; Bertrand J Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):367-74. PubMed ID: 3324927 [TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? Bessone F World J Gastroenterol; 2010 Dec; 16(45):5651-61. PubMed ID: 21128314 [TBL] [Abstract][Full Text] [Related]
15. Eosinophilic hepatitis after ingestion of choline magnesium trisalicylate. Nadkarni MM; Peller CA; Retig J Am J Gastroenterol; 1992 Jan; 87(1):151-3. PubMed ID: 1728115 [TBL] [Abstract][Full Text] [Related]
16. [Severe hepatitis from therapeutic doses of paracetamol in an alcoholic patient]. Andreu V; Gómez-Angelats E; Bruguera M; Rodés J Gastroenterol Hepatol; 1999 May; 22(5):235-7. PubMed ID: 10396106 [TBL] [Abstract][Full Text] [Related]
17. Beware of paracetamol use in alcohol abusers: a potential cause of acute liver injury. Manchanda A; Cameron C; Robinson G N Z Med J; 2013 Sep; 126(1383):80-4. PubMed ID: 24157994 [TBL] [Abstract][Full Text] [Related]
18. Toxic encephalopathy with hyperammonaemia during high-dose salicylate therapy. Mäkelä AL; Lang H; Korpela P Acta Neurol Scand; 1980 Mar; 61(3):146-56. PubMed ID: 7395459 [TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity associated with choline magnesium trisalicylate: case report and review of salicylate-induced hepatotoxicity. Cersosimo RJ; Matthews SJ Drug Intell Clin Pharm; 1987; 21(7-8):621-5. PubMed ID: 3301251 [TBL] [Abstract][Full Text] [Related]